MW 481.3 Da, Purity >99%. Potent, non-selective LXR agonist (EC = 50 nM). Increases ABCA1 expression associated with cholesterol efflux regulation and HDL metabolism. Increases muscle expression of PPAR-. Shows antiobesogenic effects in vivo. .
The product is subject to the following: Abcam Restricted Use Statement